Movatterモバイル変換


[0]ホーム

URL:


CN103169651B - A kind of injection containing docetaxel and preparation method thereof - Google Patents

A kind of injection containing docetaxel and preparation method thereof
Download PDF

Info

Publication number
CN103169651B
CN103169651BCN201210595651.0ACN201210595651ACN103169651BCN 103169651 BCN103169651 BCN 103169651BCN 201210595651 ACN201210595651 ACN 201210595651ACN 103169651 BCN103169651 BCN 103169651B
Authority
CN
China
Prior art keywords
tween
docetaxel
absolute ethyl
ethyl alcohol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210595651.0A
Other languages
Chinese (zh)
Other versions
CN103169651A (en
Inventor
张萌
孙品
魏衍纲
孙峰京
李明丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CISEN PHARMACEUTICAL Co Ltd
Original Assignee
CISEN PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CISEN PHARMACEUTICAL Co LtdfiledCriticalCISEN PHARMACEUTICAL Co Ltd
Priority to CN201210595651.0ApriorityCriticalpatent/CN103169651B/en
Publication of CN103169651ApublicationCriticalpatent/CN103169651A/en
Application grantedgrantedCritical
Publication of CN103169651BpublicationCriticalpatent/CN103169651B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Landscapes

Abstract

The invention discloses a kind of injection containing docetaxel and preparation method thereof, belong to field of pharmaceutical preparations.Compared with prior art, the absolute ethyl alcohol added when removing dispensing using the method for revolving in the preparation process of the injection, while significantly shortening the production time, improve production efficiency, reduce labour cost and energy cost, the stability of injection docetaxel is greatly improved, there is good application value.

Description

A kind of injection containing docetaxel and preparation method thereof
Technical field
The present invention relates to field of pharmaceutical preparations, specifically a kind of injection containing docetaxel and preparation method thereof.
Background technology
Docetaxel is a kind of semi-synthetic paclitaxel derivatives, is now used for Several Kinds of Malignancy, is identified as making so farOne of more significant cancer therapy drug of modern curative effect.Its anticancer mechanism is by promoting new report microtubule polymerization, preventing micro-pipe normalPhysiology depolymerization, influenceing cell has private fission process, there is good growth inhibition and apoptosis-induced to kinds of tumors, butThe antitumous effect and toxic side effect of docetaxel will be substantially better than taxol.Docetaxel is now used clinically for treating mammary glandThe malignant tumours such as cancer, oophoroma and non-small cell lung cancer have obtained the effect of preferable, and its antitumor field is more and more wider in recent years.The dosage form of its application clinically is ejection preparation.
Prepared by the preparation technology that the used docetaxel injection preparation of in the market employs lyophilized formulations, but shouldKind has difference again with general lyophilized formulations.In general lyophilized formulations to be powdered, and the products application form be will be moreXi Tasai is dissolved in inside absolute ethyl alcohol and Tween 80, liquid preparation obtained from removing absolute ethyl alcohol by lyophilized technique.ShouldPreparation method has the following disadvantages:1) product stability is general, and it is unqualified relevant material easily occur;2) lyophilized acc power is big, consumesEnergy is more and freeze-drying time is grown, and seriously constrains the production efficiency of the injection of docetaxel.
The content of the invention
The technical assignment of the present invention is to be directed to above-mentioned the deficiencies in the prior art, there is provided a kind of stability is good, and production efficiency is highThe injection containing docetaxel.
Further technical assignment of the invention is to provide the preparation method of above-mentioned injection.
The technical assignment of the present invention is realized in the following manner:Injection containing docetaxel, is characterized in, in its systemDuring standby, the absolute ethyl alcohol that is added when removing dispensing using the method for revolving.
It is preferred that the absolute ethyl alcohol added when removing dispensing using Rotary Evaporators.
The preparation method of above-mentioned injection comprises the following steps:
1) carbonization treatment is carried out to Tween 80 and absolute ethyl alcohol with mass ratio 0.01%-0.05% activated carbons respectively, it is standby;
2) Tween 80 of 30~40 times of docetaxel amounts is accurately weighed, is divided into two parts of a, b, the quality of two parts of Tween 80s of a, bThan for 1: 5~1: 15;
3) absolute ethyl alcohol of 2~6 times of a part Tween 80 amounts is accurately weighed, and it is uniformly mixed with a parts Tween 80;
4) a certain amount of docetaxel is added into mixed liquor obtained by step 3), stirs to docetaxel and be completely dissolved;
5) b parts Tween 80 is added in mixed liquor obtained by step 4), regulation pH value obtains admixing medical solutions to 5.0~7.0;
6) admixing medical solutions obtained by step 5) are transferred in Rotary Evaporators, 20 DEG C -40 DEG C of bath temperature of control, rotation speed60~120 revs/min of degree, vacuumizes backspin and absolute ethyl alcohol is evaporated off, obtain injection liquid;
7) injection liquid obtained by step 6) is detected into pH value, absolute ethyl alcohol residual quantity, qualified rear filling, tamponade, rolls lidProduce targeted injection agent.
Injection containing docetaxel of the present invention and preparation method thereof has with following prominent compared with prior artBeneficial effect:
(1) by stability contrast test, in the case where any stabilizer need not be added, the more west of the present invention heThe stability of match injection is still improved largely;
(2) production time is short, production efficiency is high, can effectively reduce labour cost and energy cost;
(3) 90% absolute ethyl alcohol can be recovered and reuse, and Material Cost is greatly reduced.
Embodiment
It is following to injection containing docetaxel of the present invention and preparation method thereof work detailed to prepare embodiment and test exampleCarefully illustrate.
【Prepare embodiment】
Preparation process:
1) carbonization treatment is carried out to Tween 80 and absolute ethyl alcohol with mass ratio 0.01%-0.05% activated carbons respectively, it is standby;
2) 2.977Kg Tween 80s accurately are weighed, is divided into two parts of a, b, a parts tween is 0.37Kg, and b part Tween 80s are2.607Kg;
3) 1.8Kg absolute ethyl alcohols accurately are weighed, and it is uniformly mixed with a parts Tween 80;
4) 0.0944Kg docetaxels are added into mixed liquor obtained by step 3), stirs to docetaxel and is completely dissolved;
5) b parts Tween 80 is added in mixed liquor obtained by step 4), with 0.1mol/L hydrochloric acid or 0.1mol/L sodium hydroxidesSolution adjusts pH value to 5.0~7.0, obtains admixing medical solutions;
6) admixing medical solutions obtained by step 5) are transferred in Rotary Evaporators, 20 DEG C -40 DEG C of bath temperature of control, rotation speed60~120 revs/min of degree, vacuumizes backspin and absolute ethyl alcohol is evaporated off, obtain injection liquid;
7) injection liquid obtained by step 6) is detected into pH value, absolute ethyl alcohol residual quantity, qualified rear filling, tamponade, rolls lidProduce targeted injection agent.
【Test example one】
Target product:Amount of preparation is 10L, and injection specification is 2ml: 80mg;
Production method:Preparation method of the present invention, traditional lyophilized technique.
Condition of production contrast see the table below:
It may determine that the inventive method is significantly better than prior art from production time, equipment power consumption and Material Cost.
【Test example two】
Test products:Prepare embodiment products obtained therefrom;Commercially available prod;
Experimental condition:40 DEG C ± 2 DEG C of temperature, humidity 75% ± 5%.
Contrast on effect situation is investigated to see the table below:
It was found from experimental data, by product produced by the invention, because the production technology cycle is short compared with lyophilized technique, it is given birth toOutput carrys out product stability and is better than commercialized product, and its stability is especially prominent in terms of relevant material.

Claims (1)

CN201210595651.0A2012-12-262012-12-26A kind of injection containing docetaxel and preparation method thereofActiveCN103169651B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201210595651.0ACN103169651B (en)2012-12-262012-12-26A kind of injection containing docetaxel and preparation method thereof

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201210595651.0ACN103169651B (en)2012-12-262012-12-26A kind of injection containing docetaxel and preparation method thereof

Publications (2)

Publication NumberPublication Date
CN103169651A CN103169651A (en)2013-06-26
CN103169651Btrue CN103169651B (en)2018-01-19

Family

ID=48630146

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201210595651.0AActiveCN103169651B (en)2012-12-262012-12-26A kind of injection containing docetaxel and preparation method thereof

Country Status (1)

CountryLink
CN (1)CN103169651B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101002761A (en)*2006-01-182007-07-25深圳万乐药业有限公司Stable injection docetaxel
CN101342143A (en)*2008-08-012009-01-14辽宁省药业有限公司Preparation of antineoplastic drug docetaxel injection
CN101862319A (en)*2010-06-282010-10-20江苏奥赛康药业有限公司 A kind of docetaxel composition for injection and preparation method thereof
CN102451155A (en)*2010-10-262012-05-16海南中化联合制药工业股份有限公司Docetaxel injection prescription and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA2611592A1 (en)*2005-06-172006-12-21Hospira Australia Pty LtdLiquid pharmaceutical formulations of docetaxel

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101002761A (en)*2006-01-182007-07-25深圳万乐药业有限公司Stable injection docetaxel
CN101342143A (en)*2008-08-012009-01-14辽宁省药业有限公司Preparation of antineoplastic drug docetaxel injection
CN101862319A (en)*2010-06-282010-10-20江苏奥赛康药业有限公司 A kind of docetaxel composition for injection and preparation method thereof
CN102451155A (en)*2010-10-262012-05-16海南中化联合制药工业股份有限公司Docetaxel injection prescription and preparation method thereof

Also Published As

Publication numberPublication date
CN103169651A (en)2013-06-26

Similar Documents

PublicationPublication DateTitle
CN102898406B (en)Cabazitaxel crystal and preparation method thereof
CN104857517B (en)A kind of miscellaneous Shandong amine soft capsule of grace and preparation method thereof
CN106165905B (en) A kind of calcium and vitamin soft capsule and preparation method
CN103169651B (en)A kind of injection containing docetaxel and preparation method thereof
CN102895183A (en)Cabazitaxel for injection and preparation method thereof
CN1202135C (en)Chi lucid ganoderma polysaccharide and prep. and use thereof
CN105434446B (en)Triptolide traditional Chinese medicine compound film coating agent and preparation method and application thereof
CN106674323A (en)Pentacyclic triterpenes compound with ACC1 protein regulation effect and use of pentacyclic triterpenes compound
CN106757135A (en)A kind of method for producing the water thing of L- cysteine hydrochlorides one
CN104490750A (en)Spirolactone composition freeze-dried tablets and preparation method thereof
CN106474097B (en)Anticancer agent
CN113509481A (en)MiRNA (micro ribonucleic acid) interferent capable of potentially regulating and controlling leukemia and application thereof
CN108309985B (en)Anticancer medicine composition
CN107362158B (en) Use of loganin in the preparation of antitumor drugs
CN105267164A (en)Thioctic acid dispersible tablet and preparation method thereof
CN104829653B (en)A kind of oxaliplatin hydrate crystal and lyophilized injectable powder thereof
CN104523629A (en)Lisinopril composition freeze-dried tablets and preparation method thereof
CN102614137B (en)Gemcitabine hydrochloride freeze-dried powder injection and preparation method thereof
CN104257641B (en)A kind of C36Polyacetylene compound and preparation thereof and application
CN108606961B (en)Levolipoic acid and lysine salt soft capsule and preparation method thereof
CN102477039A (en)Preparation method of Fissistigma Oldhamii lactam alkali compound and application of Fissistigma Oldhamii lactam alkali compound in preparation of antitumor drugs
CN102295654B (en)Cefoxitin compound and composition thereof
CN108794469A (en)A kind of new technique for synthesizing of azole compounds and the purposes of antitumor action
CN104546683A (en)Carbocisteine composition freeze-drying tablet and preparation method thereof
CN1240383C (en)Sophoridine soft capsule for curing malignant tumor and its preparation method

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
CB03Change of inventor or designer information

Inventor after:Zhang Meng

Inventor after:Sun Pin

Inventor after:Wei Yangang

Inventor after:Sun Fengjing

Inventor after:Li Mingli

Inventor before:Li Ruiming

Inventor before:Sun Fengjing

Inventor before:Li Mingli

Inventor before:Lu Xiu

CB03Change of inventor or designer information
GR01Patent grant
GR01Patent grant

[8]ページ先頭

©2009-2025 Movatter.jp